Eric d'Esparbes
2023 - BIORA THERAPEUTICS
In 2023, Eric d'Esparbes earned a total compensation of $1.6M as Chief Financial Officer at BIORA THERAPEUTICS, a 5% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $225,573 |
|---|---|
| Salary | $500,816 |
| Stock Awards | $848,997 |
| Other | $21,870 |
| Total | $1,597,256 |
d'Esparbes received $849K in stock awards, accounting for 53% of the total pay in 2023.
d'Esparbes also received $225.6K in non-equity incentive plan, $500.8K in salary and $21.9K in other compensation.
Rankings
In 2023, Eric d'Esparbes' compensation ranked 741st out of 2,978 executives tracked by ExecPay. In other words, d'Esparbes earned more than 75.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 741 out of 2,978 | 75th |
Division Manufacturing | 423 out of 1,637 | 74th |
Major group Chemicals And Allied Products | 286 out of 906 | 68th |
Industry group Drugs | 280 out of 869 | 68th |
Industry Pharmaceutical Preparations | 185 out of 627 | 71st |
Source: SEC filing on October 23, 2024.
d'Esparbes' colleagues
We found two more compensation records of executives who worked with Eric d'Esparbes at BIORA THERAPEUTICS in 2023.
News
BIORA THERAPEUTICS CEO Adi Mohanty's 2023 pay slips 11% to $3.1M
April 24, 2024
BIORA THERAPEUTICS CEO Adi Mohanty's 2022 pay falls 65% to $3.5M
April 27, 2023
BIORA THERAPEUTICS CEO Adi Mohanty receives $10M in 2021
April 28, 2022
BIORA THERAPEUTICS CEO Harry Stylli's 2020 pay jumps 1,357% to $5.8M
April 15, 2021
Innoviva CEO Michael Aguiar's 2018 pay slips 11% to $3.7M
March 13, 2019